home / stock / biov:cc / biov:cc news

BIOV:CC News and Press, Biovaxys Technology Corp. From 09/28/22

Stock Information
Company Name: Biovaxys Technology Corp.
Stock Symbol: BIOV:CC
Market: CNQC
Website: biovaxys.com
Menu
BIOV:CC BIOV:CC Quote BIOV:CC Short BIOV:CC News BIOV:CC Articles BIOV:CC Message Board
Get BIOV:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BIOV:CC - BioVaxys Further Expands Vaccines Intellectual Property Portfolio

BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...
BIOV:CC - BIOVAXYS CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

BIOVAXYS CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , Sept. 19, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announce that it has cl...

BIOV:CC - BioVaxys Announces New Chief Financial Officer

BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...

BIOV:CC - BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study

BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BIOV:CC - BIOVAXYS ANNOUNCES WARRANT EXTENSION

BIOVAXYS ANNOUNCES WARRANT EXTENSION Canada NewsWire VANCOUVER, BC , Aug. 9, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( " BioVaxys " or the " Company ") announces that it has extended the expiry dat...

BIOV:CC - BIOVAXYS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

BIOVAXYS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, British Columbia , Aug. 4, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announce a non-brokered ...

BIOV:CC - BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT

BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , Aug. 2, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") further to its news release dated July 4, 2022 , Bi...
BIOV:CC - BIOVAXYS ANNOUNCES PROPOSED DEBT SETTLEMENT

BIOVAXYS ANNOUNCES PROPOSED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , July 4, 2022 /CNW/ - BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that is proposing to settle an aggregat...

BIOV:CC - Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development Canada NewsWire VANCOUVER, BC , June 15, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVA...

BIOV:CC - Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study Canada NewsWire VANCOUVER, BC , June 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), anno...
Previous 10 Next 10